| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/17/2007 | CN1294987C Use of cTn I in preparation of anticancer medicine |
| 01/17/2007 | CN1294808C Method for preparing sterile transgenic fish |
| 01/16/2007 | US7164058 Isolated nucleic acids; restore fertility to plants |
| 01/16/2007 | US7164057 Transcription factor stress-related proteins and methods of use in plants |
| 01/16/2007 | US7164010 Metallothionein containing manganese and cadmium |
| 01/16/2007 | US7164009 Pro9821 polypeptides |
| 01/16/2007 | US7164008 Water soluble; binds toll-like receptors |
| 01/16/2007 | US7164007 Antitumor agents; anticancer agents; wound healing agents; cardiovascular disorders |
| 01/16/2007 | US7164006 For altering the growth, organization, and differentiation of plant tissues |
| 01/16/2007 | US7164005 Microencapsulation and sustained release of biologically active polypeptides |
| 01/16/2007 | US7164004 Human tumor necrosis factor TR20 and methods based thereon |
| 01/16/2007 | US7164003 Formed by splicing, genetic deletions, point mutations; vectors; host cells |
| 01/16/2007 | US7164002 FVIIa antagonists |
| 01/16/2007 | US7164001 Compositions and methods for the treatment of immune related diseases |
| 01/16/2007 | US7164000 RANTES mutants and therapeutic applications thereof |
| 01/16/2007 | US7163919 injecting into the tumor itself of a patient with a daily dose of between 1 and 5 mg of composition of citric acid, zinc, albumin and carrier |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163820 genetic element (plasmid) of that strain responsible for enterotoxin (STa, STb) production was removed, while the toxin-negative Escherichia coli strain EC2173 (NBI/36) could retain the ability to produce its original fimbriae (F18ac) facilitating its intestinal colonization |
| 01/16/2007 | US7163817 Clot-specific streptokinase proteins possessing altered plasminogen activation characteristics and a process for their preparation |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163806 mammalian therapeutics free from prion contamination |
| 01/16/2007 | US7163805 Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein |
| 01/16/2007 | US7163802 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 01/16/2007 | US7163801 Diagnosing tumors by monitor concentration and expression of tumor up regulated card containing antagonist of caspase nine (TUCAN) polypeptides; monitoring success of treatments with antitumor agents |
| 01/16/2007 | US7163800 Methods of screening compositions for G protein-coupled receptor desensitization inhibitory activity |
| 01/16/2007 | US7163799 Neuromedin U receptor NMUR2 and nucleotides encoding it |
| 01/16/2007 | US7163798 Method of preparing cow brain homogenate |
| 01/16/2007 | US7163797 50 human secreted proteins |
| 01/16/2007 | US7163795 Methods and compositions for pearl oyster cultivation |
| 01/16/2007 | US7163793 Preparing immunoglobulins for use as tools in prevention of DNA and RNA degradation during molecular analysis; enzyme inhibitors |
| 01/16/2007 | US7163701 Therapy for nervous system disorders; administering nerve growth factor |
| 01/16/2007 | US7163695 Histidine copolymer and methods for using same |
| 01/16/2007 | US7163686 Protein A based binding domains with desirable activities |
| 01/16/2007 | US7163685 DNA encoding one or more human cytomegalovirus proteins selected from pp65, pp150, IE1, gB and antigenic fragments |
| 01/16/2007 | US7163684 Method of increasing bone toughness and stiffness and reducing fractures |
| 01/16/2007 | US7163683 Inducing specific B cell anergy to an immunogen comprising a conjugate of a nonimmunogenic valency platform molecule and an analog of the immunogen that (a) binds specifically to B cells to which the immunogen binds and (b) lacks the T cell epitope(s) of the immunogen |
| 01/16/2007 | US7163682 For inducing antibody production against Streptococcal antigens |
| 01/16/2007 | CA2293682C Stable particle in liquid formulations |
| 01/16/2007 | CA2252055C Fusogenic liposomes |
| 01/16/2007 | CA2232240C Peptide for inhibiting growth of smooth muscle cells |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/13/2007 | CA2849833A1 Improved milk production in diary cattle containing polymorphism in lectin-like oxidized ldl receptor (olri) gene |
| 01/11/2007 | WO2007005928A2 Oleosin genes and promoters from coffee |
| 01/11/2007 | WO2007005912A2 Compositions for treating wounds and processes for their preparation |
| 01/11/2007 | WO2007005840A2 Compositions, kits and methods pertaining to stability modulation of pna oligomer/nucleic acid complexes |
| 01/11/2007 | WO2007005766A1 Genomic nucleic acid sequence for cyanovirin-n and signal peptide thereof |
| 01/11/2007 | WO2007005647A2 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 01/11/2007 | WO2007005627A2 Tuberculosis antigen detection assays and vaccines |
| 01/11/2007 | WO2007005612A2 An integrated approach for generating multidomain protein therapeutics |
| 01/11/2007 | WO2007005608A2 Il-12/p40 binding proteins |
| 01/11/2007 | WO2007005389A1 F11 receptor (f11r) antagonists as therapeutic agents |
| 01/11/2007 | WO2007005359A1 Composition and method for producing stable amyloid beta oligomers of high molecular weight |
| 01/11/2007 | WO2007005244A1 Henipavirus receptor and uses thereof |
| 01/11/2007 | WO2007004654A1 Mutant pcna |
| 01/11/2007 | WO2007004587A1 Malignant tumor cell suppressor protein, malignant tumor cell suppressor gene, malignant tumor cell suppressive viral vector, and kit using the same |
| 01/11/2007 | WO2007004341A1 Rna-binding peptide |
| 01/11/2007 | WO2007004325A1 Protein preparation containing s1-5 |
| 01/11/2007 | WO2007003640A1 Serum-free culture medium for the production of recombinant gonadotropins |
| 01/11/2007 | WO2007003384A1 Anti-malaria vaccine |
| 01/11/2007 | WO2006128176A3 Composite molecules comprising g-csf function |
| 01/11/2007 | WO2006120455A3 Ovalbumin promoter constructs for retroviral vectors |
| 01/11/2007 | WO2006119461A3 Rat and mouse members of the crisp family of genes |
| 01/11/2007 | WO2006117565A3 Glucagon-like-peptide-2 (glp-2) analogues |
| 01/11/2007 | WO2006113767A3 Hgf beta chain variants |
| 01/11/2007 | WO2006110589A3 Gammaretrovirus associated with cancer |
| 01/11/2007 | WO2006108818A3 Trimeric peptides for use in treating obesity |
| 01/11/2007 | WO2006107945A3 Use of rip in treating staphylococcus aureus infections |
| 01/11/2007 | WO2006106519A3 Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds |
| 01/11/2007 | WO2006105344A3 Methods for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 01/11/2007 | WO2006102188A9 Methods and compositions involving the s-ship promoter |
| 01/11/2007 | WO2006100089A3 Identification of surface-associated antigens for tumor diagnosis and therapy |
| 01/11/2007 | WO2006082313A3 T cd4+ epitopes of type i and ii latency antigens of the epstein-barr virus, which can be recognised by the majority of individuals in the caucasian population and applications thereof |
| 01/11/2007 | WO2006074390A3 Methods of treating obesity with combination therapeautics of igf-i fusion polypeptides |
| 01/11/2007 | WO2006061219A3 Il-7 variants with reduced immunogenicity |
| 01/11/2007 | WO2006052489A3 T cell proteins and nucleotides encoding the same |
| 01/11/2007 | WO2006042263A3 Phosphoprotein affinity resins and methods for making and using the same |
| 01/11/2007 | WO2006030445A3 Isolated polypeptides and polynucleotides encoding same for generating plants with increased cuticlar water permeability |
| 01/11/2007 | WO2005120215A8 The shine clade of transcription factors and their use |
| 01/11/2007 | WO2005118821A9 Generation of plants with altered oil content |
| 01/11/2007 | WO2005086750A3 Prohormone convertase 1 mutation associated with obesity |
| 01/11/2007 | US20070011780 Cloning of novel gene sequences expressed and repressed during winter dormancy in the apical buds of tea |
| 01/11/2007 | US20070011779 Regulation of growth in plants |
| 01/11/2007 | US20070011772 Polynucleotides encoding a beta-glucosidase and uses thereof |
| 01/11/2007 | US20070011763 Expression vector comprising nucleotide sequences coding ammonium transport protein for use in enhancement of nitrogen assimilation in plants |
| 01/11/2007 | US20070011760 Nucleic acids that control seed and fruit development in plants |
| 01/11/2007 | US20070011757 Transgenic rodents as animal models for modulation of B1 bradykinin receptor protein |
| 01/11/2007 | US20070011755 Diabetes type 2 animal model |
| 01/11/2007 | US20070010952 Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them |
| 01/11/2007 | US20070010949 Crystal structures of YHHF polypeptides |
| 01/11/2007 | US20070010948 G protein-coupled receptor structural model and a method of designing ligand binding to g protein-coupled receptor by using the structural model |
| 01/11/2007 | US20070010665 Nucleic acid and amino acid sequences relating to M. catarrhalis for diagnostics and therapeutics |
| 01/11/2007 | US20070010662 VGF fusion polypeptides |
| 01/11/2007 | US20070010661 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/11/2007 | US20070010660 G-CSF Conjugates |
| 01/11/2007 | US20070010659 solubility of the variant is improved by at least 3-fold relative to residues 110-244 of human adiponectin; increased soluble expression and stability, lower immunogenicity, and improved pharmacokinetics and/or pharmacodynamics |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010657 Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases |
| 01/11/2007 | US20070010540 ;Crystal proteins; antineoplastic agents for colon or breast carcinoma; diamino-pyrimidine Colony stimulating factors (cFMS) inhibitors like 5-{3-methoxy-4-[(4-methoxybenzyl)oxy]benzyl}pyrimidine-2,4-diamine; drug screening |
| 01/11/2007 | US20070010452 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |